Clinical presentation and differential splicing of SRSF2, U2AF1 and SF3B1 mutations in patients with acute myeloid leukemia
暂无分享,去创建一个
W. Hiddemann | K. Metzeler | S. Bohlander | H. Blum | K. Spiekermann | U. Mansmann | W. Berdel | S. Krebs | J. Braess | M. Sauerland | D. Görlich | S. Canzar | B. Woermann | M. Rothenberg-Thurley | T. Herold | A. Graf | V. Jurinovic | Stefanos A. Bamopoulos | S. Schneider | N. Konstandin | B. Ksienzyk | Julia Philippou-Massier | Hanna Janke | A. Batcha | J. Philippou-Massier
[1] K. Yoshizawa,et al. Macroscopic Polarization Change via Electron Transfer in a Valence Tautomeric Cobalt Complex , 2020, Nature Communications.
[2] M. Wilkins,et al. RNA splicing alterations induce a cellular stress response associated with poor prognosis in AML , 2020, bioRxiv.
[3] A. Krainer,et al. Coordinated Alterations in RNA Splicing and Epigenetic Regulation Drive Leukemogenesis , 2019, Nature.
[4] G. Dreyfuss,et al. U1 snRNP regulates cancer cell migration and invasion , 2019, bioRxiv.
[5] M. González-Díaz,et al. Focal Adhesion Genes Refine the Intermediate-Risk Cytogenetic Classification of Acute Myeloid Leukemia , 2018, Cancers.
[6] A. Gavin,et al. Impact of spliceosome mutations on RNA splicing in myelodysplasia: dysregulated genes/pathways and clinical associations. , 2018, Blood.
[7] Beth Wilmot,et al. Functional Genomic Landscape of Acute Myeloid Leukemia , 2018, Nature.
[8] M. Cazzola,et al. Aberrant splicing and defective mRNA production induced by somatic spliceosome mutations in myelodysplasia , 2018, Nature Communications.
[9] Angela N. Brooks,et al. Full-length transcript characterization of SF3B1 mutation in chronic lymphocytic leukemia reveals downregulation of retained introns , 2018, Nature Communications.
[10] Stanley W. K. Ng,et al. Prediction of acute myeloid leukaemia risk in healthy individuals , 2018, Nature.
[11] G. Stefani,et al. SRSF2 mutations drive oncogenesis by activating a global program of aberrant alternative splicing in hematopoietic cells , 2018, Leukemia.
[12] K. Akashi,et al. Dual inhibition of EZH1/2 breaks the quiescence of leukemia stem cells in acute myeloid leukemia , 2018, Leukemia.
[13] C. Shao,et al. The Augmented R-Loop Is a Unifying Mechanism for Myelodysplastic Syndromes Induced by High-Risk Splicing Factor Mutations. , 2018, Molecular cell.
[14] Dong-Eun Kim,et al. SRSF2 directly inhibits intron splicing to suppresses cassette exon inclusion , 2017, BMB reports.
[15] Rob Patro,et al. Salmon provides fast and bias-aware quantification of transcript expression , 2017, Nature Methods.
[16] Geet Duggal,et al. Salmon: fast and bias-aware quantification of transcript expression using dual-phase inference , 2017, Nature Methods.
[17] Bob Löwenberg,et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. , 2017, Blood.
[18] T. Morio,et al. EWSR1/ELF5 induces acute myeloid leukemia by inhibiting p53/p21 pathway , 2016, Cancer science.
[19] Omar Abdel-Wahab,et al. Therapeutic targeting of splicing in cancer , 2016, Nature Medicine.
[20] Jeremy M. Stark,et al. Myelodysplasia-associated mutations in serine/arginine-rich splicing factor SRSF2 lead to alternative splicing of CDC25C , 2016, BMC Molecular Biology.
[21] W. Hiddemann,et al. Spectrum and prognostic relevance of driver gene mutations in acute myeloid leukemia. , 2016, Blood.
[22] Nicola D. Roberts,et al. Genomic Classification and Prognosis in Acute Myeloid Leukemia. , 2016, The New England journal of medicine.
[23] Saijuan Chen,et al. Genetic landscape of recurrent ASXL1, U2AF1, SF3B1, SRSF2, and EZH2 mutations in 304 Chinese patients with myelodysplastic syndromes , 2016, Tumor Biology.
[24] S. Roman-Roman,et al. Cancer-associated SF3B1 mutations affect alternative splicing by promoting alternative branchpoint usage , 2016, Nature Communications.
[25] J. Qian,et al. The prognostic implication of SRSF2 mutations in Chinese patients with acute myeloid leukemia , 2016, Tumor Biology.
[26] Chieh-Yu Liu,et al. Splicing factor mutations predict poor prognosis in patients with de novo acute myeloid leukemia , 2016, Oncotarget.
[27] M. Blanchette,et al. A Function for the hnRNP A1/A2 Proteins in Transcription Elongation , 2015, PloS one.
[28] R. Fulton,et al. Mutant U2AF1 Expression Alters Hematopoiesis and Pre-mRNA Splicing In Vivo. , 2015, Cancer cell.
[29] H. Deeg,et al. SRSF2 Mutations Contribute to Myelodysplasia by Mutant-Specific Effects on Exon Recognition. , 2015, Cancer cell.
[30] Marie-Liesse Asselin-Labat,et al. Why weight? Modelling sample and observational level variability improves power in RNA-seq analyses , 2015, Nucleic acids research.
[31] Sang Hyuk Park,et al. Preferential occurrence of spliceosome mutations in acute myeloid leukemia with preceding myelodysplastic syndrome and/or myelodysplasia morphology , 2015, Leukemia & lymphoma.
[32] Matthew E. Ritchie,et al. limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.
[33] M Cazzola,et al. Disruption of SF3B1 results in deregulated expression and splicing of key genes and pathways in myelodysplastic syndrome hematopoietic stem and progenitor cells , 2014, Leukemia.
[34] L. Ding,et al. U2AF1 Mutations Alter Sequence Specificity of pre-mRNA Binding and Splicing , 2014, Leukemia.
[35] Ulrich Mansmann,et al. Isolated trisomy 13 defines a homogeneous AML subgroup with high frequency of mutations in spliceosome genes and poor prognosis. , 2014, Blood.
[36] Charity W. Law,et al. voom: precision weights unlock linear model analysis tools for RNA-seq read counts , 2014, Genome Biology.
[37] M. Stratton,et al. Clinical and biological implications of driver mutations in myelodysplastic syndromes. , 2013, Blood.
[38] J. Maciejewski,et al. Patterns of missplicing due to somatic U2AF1 mutations in myeloid neoplasms. , 2013, Blood.
[39] A. Quintás-Cardama,et al. The Changing Mutational Landscape of Acute Myeloid Leukemia and Myelodysplastic Syndrome , 2013, Molecular Cancer Research.
[40] Christopher D. Brown,et al. CUX1 is a haploinsufficient tumor suppressor gene on chromosome 7 frequently inactivated in acute myeloid leukemia. , 2013, Blood.
[41] B. Ko,et al. The clinical implication of SRSF2 mutation in patients with myelodysplastic syndrome and its stability during disease evolution. , 2012, Blood.
[42] M. Gönen,et al. Genetic analysis of patients with leukemic transformation of myeloproliferative neoplasms shows recurrent SRSF2 mutations that are associated with adverse outcome. , 2012, Blood.
[43] Michael Heuser,et al. Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromes. , 2012, Blood.
[44] A. Jankowska,et al. Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis. , 2012, Blood.
[45] W. Huber,et al. Detecting differential usage of exons from RNA-seq data , 2012, Genome research.
[46] Li Ding,et al. RECURRENT MUTATIONS IN THE U2AF1 SPLICING FACTOR IN MYELODYSPLASTIC SYNDROMES , 2011, Nature Genetics.
[47] Peter J Campbell,et al. Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms , 2011, Blood.
[48] M. Stratton,et al. Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts. , 2011, The New England journal of medicine.
[49] S. Sugano,et al. Frequent pathway mutations of splicing machinery in myelodysplasia , 2011, Nature.
[50] P. Robinson,et al. Whole-exome sequencing for finding de novo mutations in sporadic mental retardation , 2010, Genome Biology.
[51] M. Robinson,et al. A scaling normalization method for differential expression analysis of RNA-seq data , 2010, Genome Biology.
[52] Mark D. Robinson,et al. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data , 2009, Bioinform..
[53] B. Blencowe,et al. The Acute Myeloid Leukemia-Associated Protein, Dek, Forms a Splicing-Dependent Interaction with Exon-Product Complexes , 2000, The Journal of cell biology.
[54] Jae-seok Roe,et al. The Essential Transcriptional Function of BRD4 in Acute Myeloid Leukemia. , 2016, Cold Spring Harbor symposia on quantitative biology.
[55] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[56] Thomas R. Gingeras,et al. STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..